Summary of podcast content here.
CMTA CEO Sue Bruhn, PhD, on Leading Global CMT Research & Patient Care
Episode
1
Air Date:
March 12, 2025
Simply CMT
More From Simply CMT
-
When Early Testing Shows a Program Is Worth Continuing
Some research ideas reach a point where early testing answers an important question: Is this work worth continuing? For EverTree Bio, that moment came through early work using the CMTA Preclinical Toolbox.
-
Under the Microscope: Reproductive Choices in CMT
For people living with Charcot-Marie-Tooth disease, decisions about family planning can raise complex and deeply personal questions. This Under the Microscope installment explores various reproductive options and family planning resources.